ASH 2019 | Allogeneic CAR-T technology

Name: Allogeneic CAR-T technology
Uploaded: 2019-12-06T00:00:00.000Z
Duration: 3 min 25 s
Description: Bijal Shah, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses allogeneic or 'off-the-shelf' CAR-T technologies and their pros/cons, including their persistence. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Bijal Shah • 6 Dec 2019

ASH 2019

Acute Lymphoblastic Leukemia Leukemia CAR-T

Bijal Shah, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses allogeneic or ‘off-the-shelf’ CAR-T technologies and their pros/cons, including their persistence. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.